A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance with Olaparib or Placebo for the First-Line Treatment of BRCA non-mutated Advanced Epithelial Ovarian Cancer (EOC)

  • Frentzas, Sophia (Primary Chief Investigator (PCI))
  • Ho, Gwo-Yaw (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description



StatusFinished
Effective start/end date20/09/19 → 19/09/24

Keywords

  • clinical trial
  • treatment efficacy
  • phase 3 study
  • ovarian cancer

Clinical Trial Phase

  • Phase III (a & b)